Skip to main content

Robin Schmitz, MD

House Staff
Start Year: 
Heidelberg University
Medical School: 
Heidelberg University School of Medicine

Clinical and Research Interests

  • Hepatobiliary and pancreatic surgery
  • Transplant surgery
  • Surgical oncology

What were you looking for in a residency program?

The combination of world-class surgical education and research opportunities

What are the strengths of the Duke program?

Combining clinical excellence with state-of-the-art research 


Schmitz, Robin, Dimitrios Moris, John H. Strickler, and Dan G. Blazer. “ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas.” Ann Surg Oncol, July 1, 2020.

Full Text

Schmitz, Robin, Rui Mao, Dimitrios Moris, John H. Strickler, and Dan G. Blazer. “Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma.” Ann Surg Oncol, June 18, 2020.

Full Text

Schmitz, Robin, Mohamed A. Adam, and Dan G. Blazer. “Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.” World J Surg Oncol 17, no. 1 (November 4, 2019): 180.

Full Text